🌿 Milk Thistle Silymarin Research — Clinical Trials, Dosing Protocols & Evidence Database
A curated collection of milk thistle silymarin research, clinical trials organized by liver condition, dosing protocols, bioavailability comparisons, form selection guides, and drug interaction data — all backed by peer-reviewed evidence.
Milk thistle (Silybum marianum) has been used for liver conditions for over 2,000 years, but the modern research on its active compound silymarin is where things get genuinely interesting. A 2023 systematic review of 29 randomized controlled trials found that 65.5% of studies reported reduced liver enzyme levels with silymarin supplementation [1]. For the complete guide including product reviews and action plans, see the HealthSecrets milk thistle guide.
Quick Answer
Silymarin is a complex of flavonolignans extracted from milk thistle seeds, with silybin as the most biologically active component (50–70% of the complex). It protects liver cells through antioxidant activity, membrane stabilization, toxin blockade, and stimulation of protein synthesis for liver regeneration. Clinical trials show 420–600 mg silymarin daily reduces liver enzymes in NAFLD patients, and a systematic review of 3,846 participants confirmed an excellent safety profile [1].
- 65.5% of RCTs report reduced liver enzymes with silymarin [1]
- Silybin-phosphatidylcholine complex delivers significantly superior bioavailability vs standard extracts [2]
- 420–600 mg/day is the most studied therapeutic dose range for liver conditions [3]
- Silymarin increases glutathione production in liver cells — boosting the body’s master antioxidant [4]
Table of Contents
- What Is Silymarin and How Does It Protect the Liver?
- Which Liver Conditions Has Silymarin Been Studied For?
- What Is the Best Form of Milk Thistle for Absorption?
- How Much Silymarin Should You Take? Dosing by Condition
- Does Milk Thistle Interact with Medications?
- How Does Silymarin Compare to Other Liver Supplements?
- Silymarin Dosing Protocol: Step-by-Step
- Curated Research: Silymarin Clinical Trials by Condition
- Frequently Asked Questions
- Disclaimer
- References
- Free Tools & Checklists
- Further Reading
What Is Silymarin and How Does It Protect the Liver?
Silymarin is a standardized extract from milk thistle seeds (Silybum marianum) containing a complex of flavonolignans — primarily silybin, silydianin, silychristin, and isosilybin — that collectively deliver hepatoprotective effects through at least six distinct mechanisms [4]. Silybin (also called silibinin) accounts for 50–70% of the complex and carries the strongest biological activity.
Milk thistle earned its reputation as a liver protector long before anyone understood the biochemistry. Ancient Greek physicians used it for bile duct problems. Modern research has confirmed that silymarin works through multiple pathways simultaneously — which is partly why a single herb can address such diverse liver conditions.
The Silymarin Complex: Active Compounds
| Compound | % of Complex | Primary Activity | Evidence Grade |
|---|---|---|---|
| Silybin A & B | 50–70% | Most potent hepatoprotectant; antioxidant, anti-inflammatory, membrane stabilizer | A — Extensive clinical data |
| Silychristin | 20% | Antioxidant, supports bile flow | B — Moderate |
| Silydianin | 10% | Stimulates protein synthesis in liver cells | B — Moderate |
| Isosilybin A & B | 5% | Antiproliferative; emerging cancer research | C — Early research |
| Taxifolin | ~5% | Flavonoid with antioxidant activity | B — Supporting |
How Silymarin Protects Liver Cells: Mechanism of Action
| Mechanism | What It Does | Why It Matters |
|---|---|---|
| Antioxidant activity | Scavenges free radicals and reactive oxygen species | Reduces oxidative stress — the primary driver of liver cell damage [4] |
| Cell membrane stabilization | Alters hepatocyte membrane structure to block toxin entry | Prevents poisons and drugs from penetrating liver cells |
| Protein synthesis stimulation | Activates RNA polymerase I in hepatocytes | Promotes liver cell regeneration and repair |
| Glutathione production | Increases hepatic glutathione levels by up to 35% | Boosts the liver’s primary internal antioxidant defense [5] |
| Anti-inflammatory action | Inhibits NF-κB pathway and reduces TNF-α, IL-6 | Dampens chronic liver inflammation driving fibrosis |
| Anti-fibrotic effects | Inhibits hepatic stellate cell activation | May slow or prevent progression to cirrhosis [3] |
Which Liver Conditions Has Silymarin Been Studied For?
Silymarin has clinical trial data across NAFLD/NASH, alcoholic liver disease, viral hepatitis, liver cirrhosis, drug-induced liver injury, and even acute mushroom poisoning — making it one of the most broadly studied hepatoprotective compounds in herbal medicine [3]. The quality of evidence varies by condition, and I was struck by how much the dosing protocols differ depending on the target.
Clinical Evidence Database by Condition
| Condition | # of RCTs | Typical Dose | Key Outcomes | Evidence Grade |
|---|---|---|---|---|
| NAFLD / NASH | 10+ | 420–700 mg/day silymarin, 12–48 weeks | Reduced ALT/AST; improved liver histology; reduced liver fat [6][7] | A — Strong |
| Alcoholic liver disease | 6+ | 420 mg/day, 6–24 months | 4 of 6 studies showed significant improvement in liver function markers [8] | B — Moderate |
| Hepatitis C | 3+ | 420–1,260 mg/day | Some improvement in ALT; limited effect on viral load [8] | B– — Mixed |
| Liver cirrhosis | 4+ | 420–800 mg/day, long-term | 2 studies suggest survival benefit; reduced progression [3][8] | B — Moderate |
| Drug-induced liver injury | Multiple case series | 420 mg/day preventive | Protective against acetaminophen, statin, and chemotherapy-related damage [4] | B — Moderate |
| Amanita mushroom poisoning | Case series | IV silibinin 20–50 mg/kg/day | Life-saving in acute toxic hepatitis; used in EU emergency protocols [4] | A — Strong (for IV silibinin) |
NAFLD / NASH: The Strongest Evidence Base
Non-alcoholic fatty liver disease is where milk thistle silymarin research has accumulated the most robust data. A 2023 systematic review and meta-analysis in Annals of Hepatology concluded that silymarin can regulate energy metabolism, attenuate liver damage, and improve liver histology in NAFLD patients [6]. A separate case report documented significant decreases in ALT, AST, and GGT with 140 mg silymarin three times daily in a NASH patient [7].
One large RCT tested 700 mg silymarin three times daily (2,100 mg total) for 48 weeks in 99 NASH patients. While it didn’t meet its primary endpoint (30% NAS score reduction), it showed a possible reduction in liver fibrosis — a finding that warrants larger confirmation trials [9].
Alcoholic Liver Disease
Among six controlled studies, four reported significant improvement in at least one liver function marker (aminotransferases, albumin, or malondialdehyde) compared to placebo [8]. Two studies indicated a possible survival benefit. The critical caveat: silymarin is not a substitute for reducing or stopping alcohol consumption.
What Is the Best Form of Milk Thistle for Absorption?
Silybin-phosphatidylcholine complex (phytosome) delivers statistically superior bioavailability compared to conventional silymarin tablets, according to a crossover study in 23 healthy volunteers (P < 0.0001) [2]. Standard silymarin has only 20–50% oral absorption due to poor water solubility and rapid hepatic metabolism.
This bioavailability challenge is the single biggest reason people get inconsistent results from milk thistle. If you’re using a cheap, non-standardized product, you may be getting a fraction of the therapeutic dose.
Milk Thistle Form Comparison
| Form | Bioavailability | Silymarin Content | Evidence Grade | Cost | Best For |
|---|---|---|---|---|---|
| Standardized extract (70–80% silymarin) | Moderate (20–50%) | High — standardized | A — Most clinical data uses this form | $ | General liver support; most studied |
| Silybin-phosphatidylcholine (phytosome) | High — significantly superior [2] | Concentrated silybin | A — Strong bioavailability data | $$ | Therapeutic use; NAFLD, active liver conditions |
| Silybin-PC + Vitamin E complex | High — enhanced | Silybin + synergistic nutrients | B — Meta-analysis supports efficacy in NAFLD [10] | $$ | NAFLD/NASH; combined approach |
| Liquid extract / tincture | Low-Moderate | Variable | C — Limited clinical data | $ | Convenience; mild support |
| Whole seeds | Very low | ~1.5–3% silymarin | D — Insufficient therapeutic dose | $ | Culinary use only |
| Tea | Very low | Negligible silymarin extraction | D — Not recommended therapeutically | $ | Not recommended |
Bioavailability Enhancement Strategies
- Phosphatidylcholine complexing: The most proven method — creates a lipophilic complex that crosses intestinal membranes more efficiently [2]
- Taking with dietary fat: Silymarin is fat-soluble; absorption improves 20–30% when taken with a fat-containing meal [11]
- Piperine (black pepper extract): May inhibit hepatic metabolism and increase silymarin half-life — though clinical data is still limited
- Vitamin E co-administration: The Realsil complex (silybin + PC + vitamin E) shows synergistic effects in NAFLD trials [10]
How Much Silymarin Should You Take? Dosing by Condition
For general liver support, 140–420 mg of silymarin daily (from a standardized 70–80% extract) is the most common maintenance range. Therapeutic doses for active liver disease run higher — up to 600–800 mg daily in divided doses. Clinical trials typically use treatment periods of 8–48 weeks before assessing outcomes.
Dosing Protocol by Condition
| Condition / Goal | Daily Silymarin Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| General liver maintenance | 140–280 mg | 1–2x daily with meals | Ongoing | Lowest effective dose for prevention |
| Medication liver support | 280–420 mg | 2–3x daily with meals | Duration of medication | For statin users, acetaminophen, etc. |
| NAFLD / Fatty liver | 420–600 mg | 2–3x daily with meals | 12–24 weeks minimum [6] | Consider phytosome form for better absorption |
| Alcoholic liver disease | 420 mg | 3x 140 mg with meals | 6–24 months [8] | Must reduce/stop alcohol concurrently |
| Hepatitis C (adjunct) | 420–600 mg | 2–3x daily with meals | Ongoing with medical supervision | Not a replacement for antiviral therapy |
| Liver cirrhosis | 420–800 mg | 2–3x daily with meals | Long-term under supervision [3] | Studies up to 41 months show safety |
| Acute toxin exposure | 420–600 mg | 3x daily with meals | Until resolved | Seek medical attention for serious exposures |
Why Standardization Matters: Reading the Label
This trips up a lot of people. A capsule labeled “1,000 mg milk thistle” might contain only 200 mg of actual silymarin, while a “175 mg silymarin” capsule standardized to 80% delivers 140 mg of active compounds. Here’s how to calculate your actual dose:
- Extract amount × standardization % = silymarin content
- Example: 250 mg extract × 80% standardization = 200 mg silymarin
- Look for products listing both the extract amount AND the silymarin percentage
- Target 70–80% silymarin standardization — this is the clinical standard [11]
Does Milk Thistle Interact with Medications?
Silymarin has mild inhibitory effects on CYP2C9 and CYP3A4 enzymes, but clinically significant interactions are uncommon at standard supplemental doses [4]. That said, certain drug categories warrant monitoring — especially when silymarin’s blood-sugar-lowering or antiplatelet effects could compound with medication effects.
Drug Interaction Reference
| Drug Category | Interaction Mechanism | Risk Level | Clinical Recommendation |
|---|---|---|---|
| Diabetes medications (metformin, sulfonylureas, insulin) | Additive blood sugar lowering | Moderate | Monitor blood glucose closely; may need dose adjustment |
| Blood thinners (warfarin, aspirin) | Theoretical antiplatelet effect | Low-Moderate | Monitor INR; inform prescriber |
| Statins (atorvastatin, simvastatin) | CYP3A4 inhibition may increase statin levels; but silymarin may also be hepatoprotective | Low | Potentially beneficial combo; monitor liver enzymes |
| Immunosuppressants (cyclosporine, tacrolimus) | May alter drug metabolism via CYP3A4 | Moderate | Consult transplant team before use |
| Chemotherapy agents | Variable — may protect healthy cells but theoretical concern about tumor protection | High — consult oncologist | Never self-prescribe; discuss with oncologist |
| Hormone medications (HRT, oral contraceptives) | Theoretical weak estrogenic activity | Low | Use caution with hormone-sensitive conditions |
| Benzodiazepines | CYP3A4 inhibition may slow metabolism | Low | Unlikely to be clinically significant at standard doses |
Key takeaway: At standard doses (140–600 mg silymarin/day), most interactions are theoretical rather than clinically documented. The biggest real-world concern is the additive blood sugar lowering effect in diabetic patients. When in doubt, consult your prescribing physician.
How Does Silymarin Compare to Other Liver Supplements?
Silymarin is the most extensively studied hepatoprotective herb, but it works through different mechanisms than other popular liver supplements — which means combining them often makes more sense than choosing one over another [4].
| Supplement | Primary Mechanism | Liver Conditions Studied | Evidence Grade | Complementary with Silymarin? |
|---|---|---|---|---|
| Silymarin (milk thistle) | Membrane stabilization, antioxidant, regeneration | NAFLD, ALD, hepatitis, cirrhosis, DILI | A — Most clinical data | — |
| NAC (N-Acetyl Cysteine) | Glutathione precursor; direct antioxidant | Acetaminophen toxicity, NAFLD | A — Strong | Yes — NAC boosts GSH production while silymarin protects cells directly |
| Artichoke extract | Promotes bile flow (choleretic); mild antioxidant | Dyspepsia, mild liver complaints | B — Moderate | Yes — different mechanism (bile support vs. cell protection) |
| Dandelion root | Mild choleretic; supports lipid metabolism | Limited human data | C — Mostly preclinical | Possibly — different pathways |
| Glutathione (liposomal) | Master intracellular antioxidant | Oxidative stress, detox support | B — Growing data | Yes — silymarin boosts endogenous GSH; liposomal provides exogenous GSH |
| TUDCA | Bile acid; reduces ER stress | Cholestatic liver disease | B — Moderate | Yes — targets bile pathways silymarin doesn’t |
For more on glutathione strategies, see our Evidence-Based Glutathione resource page. For comprehensive detox protocols including liver Phase I/II/III support, check out our Evidence-Based Detox Protocols.
Silymarin Dosing Protocol: Step-by-Step
Here’s a practical protocol drawn from clinical trial dosing schedules and practitioner guidelines.
12-Week Liver Support Protocol
Weeks 1–2 (Foundation):
- Choose a standardized silymarin extract (70–80% silymarin content) — phytosome form preferred for active conditions
- Start at 140 mg silymarin with breakfast and dinner (280 mg/day)
- Take with a fat-containing meal for optimal absorption
- Reduce alcohol intake; increase cruciferous vegetables
Weeks 3–4 (Therapeutic Build):
- Increase to 140 mg silymarin three times daily with meals (420 mg/day)
- Add NAC 600 mg daily for glutathione support if not already taking
- Monitor for any GI changes (rare; mild bloating or loose stools)
- Continue liver-supportive diet: garlic, turmeric, green leafy vegetables
Weeks 5–12 (Maintenance):
- Maintain 420 mg/day (or increase to 600 mg/day for NAFLD under supervision)
- Continue full protocol with consistent timing
- Consider adding vitamin E 400 IU and phosphatidylcholine 300 mg for the synergistic Realsil-type approach [10]
- Schedule liver function tests (ALT, AST, GGT) at week 12 to assess response
Ongoing Maintenance:
- If liver enzymes normalized: reduce to 140–280 mg/day maintenance
- If still elevated: continue 420–600 mg/day and consult hepatologist
- Reassess every 3–6 months with blood work
- Maintain liver-supportive lifestyle (below)
Liver-Supportive Lifestyle Factors
- Limit alcohol — even moderate intake stresses the liver
- Maintain healthy weight — visceral fat drives NAFLD progression
- Avoid unnecessary liver toxins — minimize acetaminophen, limit processed foods
- Eat liver-supporting foods — cruciferous vegetables, garlic, turmeric, beets, leafy greens
- Exercise regularly — 150+ minutes/week moderate activity reduces liver fat
- Prioritize sleep — 7–9 hours; poor sleep impairs liver regeneration cycles
Curated Research: Silymarin Clinical Trials by Condition
NAFLD / NASH
| Paper | Year | Key Finding |
|---|---|---|
| Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis | 2023 | Silymarin regulates energy metabolism, attenuates liver damage, and improves liver histology in NAFLD [6] |
| Silymarin management in NASH: case report | 2023 | 140 mg 3x/day significantly decreased ALT, AST, and GGT [7] |
| Randomized trial of silymarin for NASH (NCT02006498) | 2017 | 700 mg 3x/day for 48 weeks: no significant NAS reduction, but possible fibrosis improvement [9] |
| Silybin–phosphatidylcholine–vitamin E in NAFLD: RCT | 2012 | Realsil complex improved liver enzymes and insulin resistance [10] |
| Hepatoprotective mechanism on NAFLD via network pharmacology | 2022 | Silymarin reversed pathological hepatocyte changes in NAFLD mouse model |
Liver Enzyme Systematic Reviews
| Paper | Year | Key Finding |
|---|---|---|
| Impact of silymarin on liver enzyme levels: systematic review of 29 RCTs | 2023 | 65.5% of studies showed reduced enzymes; 3,846 participants; doses 140–420 mg [1] |
| Silymarin vs essential phospholipids in MASLD: prospective RCT | 2024 | Both effective; silymarin showed comparable outcomes to essential phospholipids [11] |
Bioavailability & Forms
| Paper | Year | Key Finding |
|---|---|---|
| Silybin–PC complex vs conventional tablets: crossover study | 2019 | Phytosome form achieved significantly superior plasma silybin levels (P < 0.0001) [2] |
| Realsil meta-analysis for NAFLD/NASH | 2020 | Silybin–PC–vitamin E complex consistently improved liver enzymes across RCTs [10] |
| Synergy of phospholipid–drug formulations | 2019 | Phospholipid complexing significantly enhanced silymarin delivery |
General Hepatoprotection & Safety
| Paper | Year | Key Finding |
|---|---|---|
| Silymarin as supportive treatment in liver diseases: narrative review | 2020 | Comprehensive review confirming anti-inflammatory, antioxidant, antifibrogenic properties [3] |
| Milk thistle: Effects on liver disease — AHRQ Evidence Report | AHRQ | 4 of 6 alcoholic liver disease studies showed significant improvement; 2 suggested survival benefit [8] |
| Long-term safety of plant-based liver nutraceutical: RCT | 2025 | No AEs or SAEs; improved ALT, AST, ALP, GGT, lipid profile, and inflammatory markers |
| NIH StatPearls — Milk Thistle | 2024 | Authoritative overview: mechanisms, clinical use, safety profile [4] |
Frequently Asked Questions
Q: What is the recommended milk thistle dosage for fatty liver disease?
A: Clinical trials for NAFLD typically use 420–600 mg of silymarin daily, divided into two or three doses taken with meals. A 2023 systematic review in Annals of Hepatology confirmed this range reduces liver enzymes and improves liver histology over 8–24 weeks [6]. Always use standardized extracts containing 70–80% silymarin.
Q: Is silymarin safe for long-term use?
A: Yes. Silymarin has an excellent safety profile in studies lasting up to 41 months. A systematic review of 29 RCTs with 3,846 participants reported no serious adverse events [1]. Mild GI symptoms occur in fewer than 5% of users. People with ragweed allergies should use caution due to potential cross-reactivity.
Q: Which form of milk thistle has the best bioavailability?
A: Silybin-phosphatidylcholine complex (phytosome) delivers significantly higher plasma silybin levels than conventional tablets — a crossover study found statistically superior absorption (P < 0.0001) [2]. Standard silymarin has only 20–50% oral absorption.
Q: Can milk thistle help with drug-induced liver injury?
A: Research suggests silymarin may protect against drug-induced liver damage from acetaminophen, statins, and chemotherapy agents. Intravenous silibinin is used in European hospitals as emergency treatment for Amanita mushroom poisoning [4]. For medication-related liver stress, 420 mg silymarin daily is commonly studied.
Q: Does milk thistle interact with prescription medications?
A: Silymarin mildly inhibits CYP2C9 and CYP3A4, but clinically significant interactions are uncommon at standard doses [4]. Monitor closely with diabetes medications (additive blood sugar lowering), blood thinners, immunosuppressants, and chemotherapy drugs. Always inform your prescribing physician.
Q: How does silymarin compare to NAC for liver support?
A: They work through complementary mechanisms. Silymarin stabilizes membranes and blocks toxins; NAC provides cysteine for glutathione production. Many practitioners recommend combining both: silymarin 420 mg + NAC 600–1,200 mg daily for comprehensive support [4][5].
Q: What should I look for when buying a milk thistle supplement?
A: Look for 70–80% silymarin standardization, third-party testing (USP, NSF, ConsumerLab), and clear labeling of silymarin content per capsule. Phytosome forms offer enhanced absorption [2]. Avoid products with proprietary blends or no standardization information.
Disclaimer
This repository is for educational purposes only. The information provided does not constitute medical advice. Consult a qualified healthcare professional before starting any supplement protocol, especially if you have liver disease, are taking medications (particularly diabetes drugs, blood thinners, immunosuppressants, or chemotherapy), are pregnant or breastfeeding, or have ragweed allergies. Milk thistle supplements are not FDA-approved to treat, cure, or prevent any disease.
References
- Kalopitas, G. et al. “Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review.” Cureus, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10667129/
- Aller, R. et al. “Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.” BMC Pharmacol Toxicol, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6330464/
- Gillessen, A. & Schmidt, H.H. “Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.” Adv Ther, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7140758/
- NIH StatPearls. “Milk Thistle.” 2024. https://www.ncbi.nlm.nih.gov/books/NBK541075/
- Pizzorno, J. “Glutathione!” Integrative Medicine, 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC4684116/
- Voroneanu, L. et al. “Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.” Annals of Hepatology, 2023. https://www.sciencedirect.com/science/article/pii/S1665268123002776
- PMC. “Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report.” 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10259499/
- AHRQ. “Milk Thistle: Effects on Liver Disease and Cirrhosis and Clinical Adverse Effects.” AHRQ Evidence Report. https://www.ncbi.nlm.nih.gov/books/NBK11896/
- Navarro, V.J. et al. “A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.” Clinical Gastroenterology and Hepatology, 2017. https://www.cghjournal.org/article/S1542-3565(17)30459-7/abstract
- Pietrangelo, A. et al. “The effects of Realsil (silybin–phospholipid–vitamin E complex) on liver enzymes in NAFLD/NASH: a systematic review and meta-analysis of RCTs.” Dig Dis Sci, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7535884/
- PMC. “Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD): A Prospective Comparative Randomized Trial.” 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11079726/
- Loguercio, C. et al. “Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial.” Free Radical Biology and Medicine, 2012. https://www.sciencedirect.com/science/article/abs/pii/S0891584912000858
- PMC. “Long-term safety and efficacy of a highly purified plant-based nutraceutical for improving clinical parameters of liver function in healthy participants.” 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12875990/
- Valentino, G. et al. “Synergy of Phospholipid–Drug Formulations Significantly Delineates the Silymarin Solubility Increase.” Nutrients, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6969915/
- Hodges, R.E. & Minich, D.M. “Modulation of metabolic detoxification pathways using foods and food-derived components.” J Nutr Metab, 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4488002/
- ClinicalTrials.gov. “Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease — The SILIVER Trial.” NCT03749070. https://clinicaltrials.gov/study/NCT03749070
- ResearchGate. “Milk Thistle and its Therapeutic Potential in Liver Disorders: A Comprehensive Review.” 2024. https://www.researchgate.net/publication/385739784
Free Tools & Checklists
📋 Free Tools: Download our 🌱 Milk Thistle & Liver Supplement Guide — a free supplement comparison, dosing protocols, and brand evaluation checklist for tracking your silymarin protocol and liver health biomarkers.
Further Reading
- 📖 HealthSecrets.com Silymarin Resource — Complete milk thistle guide with product reviews and action plans
- 📖 Evidence-Based Glutathione — Glutathione supplement evidence, precursor stacks, and protocols
- 📖 Evidence-Based Detox Protocols — Liver Phase I/II/III support, heavy metal chelation, gut detox
- 📖 Lymphatic Drainage Guide — Detox drainage pathways and protocols
- 📖 Evidence-Based Detox Guide — Health Secrets — The full detox guide on HealthSecrets.com
Contributing
Know of a clinical trial or resource we missed? Contributions are welcome! All submissions must be backed by peer-reviewed research (PubMed, Cochrane, NIH preferred) and include evidence grades and citations.
© HealthSecrets.com — Evidence-based health guides. For informational purposes only. Not medical advice.